A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease

Completed · Phase 2

Conditions studied: Pulmonary Disease, Chronic Obstructive

In brief

This an initial proof of concept, phase to study to assess the safety and efficacy of tofimilast for the chronic maintenance treatment of adults with Chronic Obstructive Pulmonary Disease

Key facts

Study ID

NCT00219622

Run by

Pfizer

People needed

300

Starts

2004-05-01

Expected to finish

2005-07-01

Last updated by the study team

2012-11-07

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Moderate-severe COPD (GOLD 2003 definition)
• Smoking history of at least 10 pack-years

You may not qualify if…

• Any significant co-morbid disease, particularly cardiovascular
• Use of any maintenance therapy except short acting bronchodilators

Where it is running

• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Riverside, California, United States
• Pfizer Investigational Site — Clearwater, Florida, United States
• Pfizer Investigational Site — Clearwater, Florida, United States
• Pfizer Investigational Site — Riverdale, Georgia, United States
• Pfizer Investigational Site — Stockbridge, Georgia, United States
• Pfizer Investigational Site — Normal, Illinois, United States
• Pfizer Investigational Site — Iowa City, Iowa, United States
• Pfizer Investigational Site — Madisonville, Kentucky, United States
• Pfizer Investigational Site — Wheaton, Maryland, United States
• Pfizer Investigational Site — Edina, Minnesota, United States
• Pfizer Investigational Site — Minneapolis, Minnesota, United States
• Pfizer Investigational Site — Buffalo, New York, United States
• Pfizer Investigational Site — Charlotte, North Carolina, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Lake Oswego, Oregon, United States
• Pfizer Investigational Site — Lincoln, Rhode Island, United States
• Pfizer Investigational Site — Spartanburg, South Carolina, United States
• Pfizer Investigational Site — Spartanburg, South Carolina, United States
• Pfizer Investigational Site — Dallas, Texas, United States
• Pfizer Investigational Site — Bellingham, Washington, United States
• Pfizer Investigational Site — Renton, Washington, United States
• Pfizer Investigational Site — Tukwila, Washington, United States
• Pfizer Investigational Site — La Plata, Buenos Aires, Argentina
• Pfizer Investigational Site — Vicente López, Buenos Aires, Argentina

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.